Chromedx Corp (MNLIF) 0.1000 $MNLIF ChroMedX Reports on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chromedx Corp (MNLIF) 0.1000 $MNLIF

ChroMedX Reports on HemoPalm Development
ACCESSWIRE - Fri Apr 29, 3:30PM CDT
TORONTO, ON / ACCESSWIRE / April 29, 2016 / ChroMedX Corp. (CSE: CHX) (OTC: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and Point-of-care Testing technologies is pleased to report on the Company's HemoPalm development programme.

ChroMedX Corp. Engages Conductive Technologies Inc. for Biosensor Development Programme
ACCESSWIRE - Wed Apr 20, 3:30PM CDT
TORONTO, ON / ACCESSWIRE / April 20, 2016 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce the engagement of Conductive Technologies Inc. (CTI) of York, Pennsylvania to assist with biosensor development on the Company's HemoPalm technology.

ChroMedX Completes Proof-of-Concept CO-oximetry and Bilirubin Prototype Development
ACCESSWIRE - Fri Dec 11, 3:21PM CST
TORONTO, ON / ACCESSWIRE / December 11, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) devices is pleased to report the development of a proof-of-concept prototype of the Company's HemoPalm(TM) analyzer and associated cartridge for measuring CO-oximetry and bilirubin*.

ChroMedX Engages Hochuen International Corp. for Improved Prototype Cartridge Production
ACCESSWIRE - Tue Dec 08, 3:17PM CST
TORONTO, ON / ACCESSWIRE / December 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that it has engaged Hochuen International Corp. to produce an enhanced version of its prototype HemoPalm cartridges.

ChroMedX Awarded a United States Patent on its Ultra Filtration Technology - Video News Alert on InvestmentPitch.com
Newsfile Corp - Tue Oct 20, 12:00PM CDT
full story)

ChroMedX Corp. Announces Closing of First Tranche of Private Placement
ACCESSWIRE - Fri Oct 16, 5:48PM CDT
TORONTO, ON / ACCESSWIRE / October 16, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it has completed the first tranche of its previously announced non-brokered private placement (the "Offering", pursuant to which the Company issued and sold an aggregate of 1,750,000 units (each, a "Unit" of the Company at a price of CDN$0.20 per Unit for aggregate gross proceeds of CDN$350,000. Each Unit is comprised of one common share of the Company (a "Common Share" and one Common Share purchase warrant (a "Warrant", each Warrant entitling the holder thereof to acquire one Common Share at a price of $0.30 for a period of twenty-four (24) months from the closing date.

ChroMedX Corp. Awarded New United States Patent on Ultra Filtration Technology
ACCESSWIRE - Wed Oct 14, 3:15PM CDT
TORONTO, ON / ACCESSWIRE / October 14, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded a United States patent on its Ultra Filtration technology.

ChroMedX Corp. Announces Private Placement of Units
ACCESSWIRE - Fri Oct 09, 7:21PM CDT
TORONTO, ON / ACCESSWIRE / October 9, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering" for gross proceeds of up to CDN$800,000 through the issuance of up to 4,000,000 units (each a "Unit" at a price of CDN$0.20 per Unit. Each Unit will be comprised of one common share of the Company (a "Common Share" and one Common Share purchase warrant (a "Warrant", each Warrant entitling the holder thereof to acquire one Common Share at a price of $0.30 for a period of twenty-four (24) months from the closing date.

ChroMedX Corp. Awarded Two New Patents on Ultra-Filtration Technology
ACCESSWIRE - Wed Sep 30, 3:12PM CDT
TORONTO, ON / ACCESSWIRE / September 30, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded two additional Canadian patents on its Automated Ultra Filtration (AUF) technology.

ChroMedX Callaborates with Biointerfaces Institute and Receives Grant
Newsfile Corp - Wed Sep 16, 3:08PM CDT
full story)

ChroMedx Reports Testing of Key HemoPalm Analyzer Component
ACCESSWIRE - Tue Sep 08, 3:31PM CDT
TORONTO, ON / ACCESSWIRE / September 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company", a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that testing has commenced on the key spectroscopic component of the Analyzer of HemoPalm(TM) blood analysis device.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 205

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 196

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 286

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 204

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 405

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 193

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 253

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 330

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 238

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Elis Capital Structure Overview and Voting Rights Update

Updated Category News Views 292

Elis Capital Structure Overview Elis, a prominent player in the services sector, is committed to providing transparency regarding its capital structure. As of the recent assessment, the company detailed the number of shares that constitute its capital along with the total number of voting rights. Share Capital and Voting Rights According to French legal requirements,...

Continue Reading
A. Walker & Company Secures $50 Million for Housing Projects

Updated Category News Views 244

A. Walker & Company Secures Major Capital Commitments A. Walker & Co. recently secured a significant capital commitment totaling up to $75 million, including an initial $50 million specifically set aside for affordable housing development. This funding is a critical step towards increasing the availability of multifamily housing that can effectively serve the needs of...

Continue Reading
ClorDiSys Enhances Sterilization Capabilities with Expansion

Updated Category News Views 228

ClorDiSys Expands Sterilization Operations ClorDiSys Solutions, LLC has announced a significant expansion in its sterilization facilities, designed to address the growing demand for its chlorine dioxide-based sterilization services. This expansion includes the addition of new chambers, which will effectively double the company’s processing capacity. With the new...

Continue Reading
Star Equity's KBS Builders Secures Major Contracts Worth $5.2M

Updated Category News Views 173

KBS Builders Secures Significant Commercial Contracts Star Equity Holdings, Inc. is excited to announce that its subsidiary, KBS Builders, has successfully signed two major contracts worth a total of $5.2 million. These contracts focus on the manufacturing of housing units, promising to contribute positively not only to KBS's growth but also to addressing the ongoing...

Continue Reading
Navigating the Startup Jungle: Break Free from Traps

Updated Category News Views 158

Understanding the Existing Market Trap A fresh approach from the creators of Play Bigger reveals the hidden costs startups face. The new book titled The Existing Market Trap: A Primer presents a timely exploration into why many startups struggle to gain traction. Co-authors Al Ramadan, Christopher Lochhead, alongside new contributors Jason Wellcome and Mary Gr

Continue Reading